Clinical Trial

Screening for NAFLD in Flanders

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-11-26; most recent amendment 2025-11-24.
Status change: Recruiting → Active, Not Recruiting 2025-11-24
Trial Details
NCT Number NCT04647409
Lead Sponsor Hasselt University
Conditions Non-Alcoholic Fatty Liver Disease
Enrollment 10,000 participants
Start Date 2020-10-26
Primary Completion 2025-04-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-01